BioCentury
ARTICLE | Financial News

Avalon raises $70 million

December 17, 2001 8:00 AM UTC

Avalon (Gaithersburg, Md.), a developer of genomics-derived cancer compounds, raised $70 million in a private round. Investors included CDP Sofinov; Euclid SR Partners; AIG; Hambrecht & Quist Ventures...